###begin article-title 0
Predominant Role of Host Genetics in Controlling the Composition of Gut Microbiota
###end article-title 0
###begin p 1
Conceived and designed the experiments: ZK RA. Performed the experiments: ZK GM KG. Analyzed the data: ZK GM KG RA. Contributed reagents/materials/analysis tools: DK RA. Wrote the paper: ZK RA.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human gastrointestinal tract is inhabited by a very diverse symbiotic microbiota, the composition of which depends on host genetics and the environment. Several studies suggested that the host genetics may influence the composition of gut microbiota but no genes involved in host control were proposed. We investigated the effects of the wild type and mutated alleles of the gene, which encodes the protein called pyrin, one of the regulators of innate immunity, on the composition of gut commensal bacteria. Mutations in MEFV lead to the autoinflammatory disorder, familial Mediterranean fever (FMF, MIM249100), which is characterized by recurrent self-resolving attacks of fever and polyserositis, with no clinical signs of disease in remission.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 418 443 418 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroidetes, Firmicutes</italic>
###xml 448 462 448 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proteobacteria</italic>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
A total of 19 FMF patients and eight healthy individuals were genotyped for mutations in the MEFV gene and gut bacterial diversity was assessed by sequencing 16S rRNA gene libraries and FISH analysis. These analyses demonstrated significant changes in bacterial community structure in FMF characterized by depletion of total numbers of bacteria, loss of diversity, and major shifts in bacterial populations within the Bacteroidetes, Firmicutes and Proteobacteria phyla in attack. In remission with no clinical signs of disease, bacterial diversity values were comparable with control but still, the bacterial composition was substantially deviant from the norm. Discriminant function analyses of gut bacterial diversity revealed highly specific, well-separated and distinct grouping, which depended on the allele carrier status of the host.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 331 336 <span type="species:ncbi:9606">human</span>
This is the first report that clearly establishes the link between the host genotype and the corresponding shifts in the gut microbiota (the latter confirmed by two independent techniques). It suggests that the host genetics is a key factor in host-microbe interaction determining a specific profile of commensal microbiota in the human gut.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Ley1">[1]</xref>
###xml 252 259 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 357 360 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Finegold1">[2]</xref>
###xml 361 364 361 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Salminen1">[4]</xref>
###xml 498 501 498 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Neish1">[5]</xref>
###xml 503 506 503 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Kelly1">[6]</xref>
###xml 554 557 554 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Backhed1">[7]</xref>
###xml 587 590 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Ley2">[8]</xref>
###xml 592 595 592 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Turnbaugh1">[9]</xref>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Stappenbeck1">[10]</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-RakoffNahoum1">[11]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
The human gut microbiota has been shaped by the long co-evolutionary history of symbiotic host-microbe interaction [1] and has evolved to play an important role in maintaining human health by preventing colonization by pathogens, degrading dietary and in situ-produced compounds, producing nutrients, and shaping and maintaining the normal mucosal immunity [2]-[4]. Recently, other important functions of commensal microbiota became apparent including an anti-inflammatory effect on gut epithelium [5], [6], the influence on lipid metabolism of the host [7] and association with obesity [8], [9] as well as the involvement in intestinal homeostasis, repair and angiogenesis [10], [11].
###end p 9
###begin p 10
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Medzhitov1">[12]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Inohara1">[13]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Kaparakis1">[14]</xref>
###xml 1181 1185 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-RakoffNahoum1">[11]</xref>
###xml 1345 1365 1345 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroides fragilis</italic>
###xml 1478 1482 1478 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Mazmanian1">[15]</xref>
###xml 1624 1628 1624 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Rachmilewitz1">[16]</xref>
###xml 1773 1777 1773 1777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Cario1">[17]</xref>
###xml 1779 1783 1779 1783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Cario2">[18]</xref>
###xml 1345 1365 <span type="species:ncbi:817">Bacteroides fragilis</span>
###xml 1487 1493 <span type="species:ncbi:10090">murine</span>
Recently, the intricate molecular mechanisms behind this host-microbe cross-talk began to emerge. The innate immune system of the mammalian host senses bacteria through an impressive array of receptors, called Toll-like (TLR) and Nod-like (NLR) (also called CATERPILLER, NOD-LRR, and NACHT-LRR) receptors. The first mammalian TLR was discovered a decade ago [12] and the functionality of the first NLRs (then called NODs) as sensors of bacterial ligands was established in 2001 [13]. TLRs are predominantly but not exclusively located in the transmembrane region of host cells, while NLR proteins are mostly located in the cytoplasm [14]. Both groups of receptors contain leucine-rich repeats (LRR), which are involved in detection of danger signals and, in particular, of whole bacteria and bacterial products through the recognition of pathogen associated molecular patterns (PAMP). PAMP signalling through the innate immunity receptors appeared to be important not only for the recognition of, and launching defences against, the invading pathogens but also for the maintenance of intestinal epithelial homeostasis and for protection against gut injury and associated mortality [11]. Bacterial products are also crucial for the normal immune system development; for example, a single bacterial polysaccharide (PSA) from a commensal bacterium Bacteroides fragilis was shown is capable of directing the complete cellular and physical maturation of the developing immune system [15]. In murine experimental colitis models, signalling by probiotic bacterial DNA ligands through TLR9 exerted a strong anti-inflammatory effect [16] while signalling through TLR2 seems important for regulation of mucosal inflammation and maintenance of intestinal epithelial barrier integrity [17], [18].
###end p 10
###begin p 11
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Hague1">[19]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Ahmad1">[21]</xref>
Another type of regulation of the host metabolism by microbes can be through the low molecular weight bacterial metabolites such as short chain fatty acids (SCFAs) and, in particular, butyrate. Butyrate is the preferred energy source for the colonic epithelium and may play an important role in colonic health and prevention of colorectal cancer and colitis [19]-[21].
###end p 11
###begin p 12
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Hooper1">[22]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Sonnenburg1">[23]</xref>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Hooper1">[22]</xref>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Meng1">[24]</xref>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Coyne1">[25]</xref>
###xml 1199 1206 1199 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1348 1352 1348 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Sperandio1">[26]</xref>
###xml 1490 1494 1490 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Wu1">[27]</xref>
###xml 1199 1206 <span type="species:ncbi:562">E. coli</span>
Because of limitations imposed by the extreme diversity of microbiota in the conventional gut, which does not allow monitoring the behaviour of a single bacterium, much less is known of how the bacterial counterpart responds to the host-generated molecular signals. Initially, the bacterial response was considered to be limited to various strategies used by gut bacteria to forage the endogenously produced substrates of the host [22], [23]. Interestingly, however, one of the aspects of this interaction, namely the specific fucosylation, seems important for both sides involved in the host-bacterial dialogue. On one side, the intestinal bacteria induce mucin fucosylation in the gut epithelium thus creating a specific nutritional econiche [22], [24]. On the other side, fucosylation of the cell surface in a mammalian-like fashion appeared to be essential for the gut bacteria to establish the successful mutualistic relationship with the host. The lack of this property may result in the failure of bacteria to colonize the mammalian intestine [25]. Yet another "language" of host-bacterial communication could be through the quorum sensing (QS), which utilizes hormone-like compounds and, in E. coli, has been implicated in a potential cross-communication between the luxS/AI-3 bacterial QS system and the epinephrine host signalling system [26]. Bacteria may also sense the immune status of the host and respond by the expression of a quorum-sensing dependent virulence determinant [27]. These two examples of quorum-sensing-mediated signalling between the host and bacteria are taken from the pathogenic bacteria but it cannot be excluded that this type of communication is common among gut symbiotic bacteria as well.
###end p 12
###begin p 13
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Hugot1">[28]</xref>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Ogura1">[29]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Inohara2">[30]</xref>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Girardin1">[31]</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Landers1">[32]</xref>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Adams1">[34]</xref>
###xml 841 851 841 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firmicutes</italic>
###xml 856 869 856 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroidetes</italic>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Manichanh1">[35]</xref>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Frank1">[36]</xref>
###xml 1139 1143 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Garrett1">[37]</xref>
###xml 234 242 <span type="species:ncbi:9606">patients</span>
###xml 498 506 <span type="species:ncbi:9606">patients</span>
###xml 732 740 <span type="species:ncbi:9606">patients</span>
###xml 1029 1035 <span type="species:ncbi:10090">murine</span>
What happens if this fine-tuned molecular cross-talk is compromised and the host fails to recognize bacterial components as, for example, in the case of inflammatory bowel disease (IBD) such as Crohn's disease (CD)? In a subset of CD patients, mutations in the NOD2/CARD15 protein have been associated with susceptibility to the disease [28], [29]. Bacterial ligand for this receptor has been recently identified as bacterial muramyl dipeptide [30], [31] and failure to recognise this ligand in CD patients leads to the breach of tolerance and to the launch of an aggressive Th1-skewed response against the antigens of normal diet and commensal bacteria as well as to production of autoantibodies [32]-[34]. The microbiota of these patients demonstrates diminished diversity, in particular, due to the depletion of bacteria belonging to the Firmicutes and Bacteroidetes phyla [35], [36]. Interestingly, the loss of the transcription factor T-bet, which regulates the innate immune system, influences bacterial populations in the murine gut in a way that they become colitogenic and this colitis is communicable to genetically intact hosts [37]. Presently, it is not clear how the composition of the normal microbiota is restructured to become a "pathobiota" but, nevertheless, this is the first experimental proof of the view that the community as a whole may demonstrate pathogenic properties, not a single pathogenic bacterium.
###end p 13
###begin p 14
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Ting1">[38]</xref>
###xml 482 486 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Brydges1">[39]</xref>
###xml 1005 1009 993 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-The1">[40]</xref>
###xml 1011 1015 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-The2">[41]</xref>
###xml 1032 1036 1020 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1134 1138 1122 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1588 1592 1576 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-VanLimbergen1">[42]</xref>
In our study, we investigated the effect of mutations in a single gene of the host on commensal gut microbiota. The gene under investigation, MEFV (for MEditerranean FeVer), encodes a protein called pyrin/marenostrin, which is involved in regulation of innate immunity [38]. Structurally, this 781-residue protein consists of a 92-amino acid N-terminal PYRIN (PYD) domain, a B-box zinc finger, a coiled-coil region and a approximately200-amino acid C-terminal B30.2/rfp/SPRY domain [39]. Mutations in this gene lead to an autoinflammatory disorder, familial Mediterranean fever (FMF, MIM249100), which is characterised by short recurrent self-resolving attacks of fever and polyserositis, with no clinical signs of disease in remission periods. The carrier rate and occurrence of disease is high in populations originating from the Mediterranean basin, including Sephardic Jews, Armenians, Arabs, and Turks. Articles describing positional cloning of the gene by two independent consortia appeared in 1997 [40], [41] and to date 166 MEFV mutations and single nucleotide polymorphisms (SNPs) are detected in the gene (). The hotspot of MEFV mutations is localized in exon 10, which encodes the B30.2/rfp/SPRY domain, and this single locus inheritance greatly facilitated our analysis of host genetics in comparison with other disorders with more complex genetics. Genome-wide scans for IBD susceptibility, for example, have resulted in identification of seven loci that are confirmed and replicated in several studies, but with many more that need independent confirmation and verification [42].
###end p 14
###begin p 15
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 151 163 <span type="species:ncbi:9606">participants</span>
###xml 562 567 <span type="species:ncbi:9606">human</span>
The present work is the first attempt to analyze simultaneously the genetics of both sides involved in the host-gut microbiota relationship. All study participants were analyzed for MEFV mutations and the composition of gut microbiomes was assessed by two culture-independent techniques, fluorescent in situ hybridization (FISH) and 16S rDNA gene library analyses. For the first time, our findings conclusively establish the key role of the host genotype in host-microbe interaction, which determines a highly specific composition of commensal microbiota in the human gut.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
MEFV Genotyping
###end title 17
###begin p 18
###xml 116 123 116 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t001">Table 1</xref>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 569 576 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t001">Table 1</xref>
###xml 1069 1076 1069 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t001">Table 1</xref>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 396 404 <span type="species:ncbi:9606">patients</span>
###xml 743 751 <span type="species:ncbi:9606">patients</span>
###xml 842 850 <span type="species:ncbi:9606">patients</span>
###xml 892 900 <span type="species:ncbi:9606">patients</span>
###xml 1219 1227 <span type="species:ncbi:9606">patients</span>
Nineteen FMF patients with clinically confirmed disease and eight healthy individuals were subjected to genotyping (Table 1). We performed genotyping of the exon regions of the MEFV gene, which is thought to be a single genetic determinant of FMF, in particular exons 2 and 10, where the majority of disease-associated mutations were identified (). FMF-associated mutations were found in all FMF patients displaying the clinical signs of the disease, as well as in one healthy Armenian control subject (in a simple heterozygous state) without disease-related symptoms (Table 1). All mutations were located in exon 10, only synonymous substitutions were detected in exon 2, irrespectively of the health status. The majority of mutations in FMF patients were M694V, which were present in the compounded form with other disease alleles in eight patients and in a simple heterozygous form in six patients. In the latter group, no other disease-related mutations in exon 2, except neutral SNPs, were detected. Homozygotes were represented exclusively by the M680I mutation (Table 1). Interestingly, the SNPs in the control group were all in the heterozygous state, while the homozygous forms were encountered only among FMF patients.
###end p 18
###begin title 19
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
MEFV genotypes of FMF patients and control subjects and gut microbiota analysis methods applied.
###end title 19
###begin p 20
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Control subjects denoted with prefix C; FMF patients denoted with prefix FMF.
###end p 20
###begin p 21
Abbreviations: S, 16S library; F, FISH analysis; SR, 16S library in FMF remission; SA, 16S library in FMF attack; FR, FISH analysis in FMF remission; FA, FISH analysis in FMF attack; HT, heterozygote; HM, homozygote.
###end p 21
###begin p 22
N/D, not detected.
###end p 22
###begin p 23
N/A, not analyzed.
###end p 23
###begin title 24
Phylogenetic and comparative analysis of 16S libraries
###end title 24
###begin p 25
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t001">Table 1</xref>
###xml 430 437 430 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t002">Table 2</xref>
###xml 559 572 559 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroidetes</italic>
###xml 626 636 626 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firmicutes</italic>
###xml 687 701 687 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proteobacteria</italic>
###xml 773 787 773 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actinobacteria</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 858 865 <span type="species:ncbi:9606">patient</span>
Three 16S rDNA libraries from the fecal samples of healthy controls as well as of FMF patients in remission and disease attack were generated (designated as S, SR and SA in Table 1). After the quality control a total of 1328 validated sequences (572 for healthy controls, 629 for FMF remission and 127 for FMF attack) were analyzed and phylogenetic analysis was performed to establish taxonomic positioning of sequences obtained (Table 2). Among 1328 clones analyzed, there were 268 distinct OTUs and the vast majority (95.95%) fell into the two major phyla, Bacteroidetes with 99 OTUs (38.15%) and 714 sequences (53.76%) and Firmicutes with 158 OTUs (57.8%) and 580 sequences (43.67%). Proteobacteria were represented by 9 OTUs (3.47%) and 30 sequences (2.26%). Only four Actinobacteria sequences (2 OTUs) were detected, which were all derived from one FMF patient in remission.
###end p 25
###begin title 26
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Phylogenetic distribution of 16S rRNA gene sequences and phylotypes retrieved from healthy individuals and FMF patients in remission and attack.
###end title 26
###begin p 27
OTUs were defined at 99% similarity level.
###end p 27
###begin p 28
###xml 50 63 50 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroidetes</italic>
###xml 263 273 263 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firmicutes</italic>
###xml 409 416 409 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t002">Table 2</xref>
###xml 468 481 468 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroidetes</italic>
###xml 486 496 486 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firmicutes</italic>
###xml 782 789 782 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t003">Table 3</xref>
###xml 868 886 868 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacteriaceae</italic>
###xml 888 906 888 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acidaminococcaceae</italic>
###xml 908 920 908 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ruminococcus</italic>
###xml 925 936 925 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Megasphaera</italic>
###xml 1008 1017 1008 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Roseburia</italic>
###xml 1045 1052 1045 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t003">Table 3</xref>
###xml 1096 1121 1096 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prevotellaceae, Dialister</italic>
###xml 1126 1136 1126 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prevotella</italic>
###xml 1196 1214 1196 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Porphyromonadaceae</italic>
###xml 1216 1237 1216 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phascolarctobacterium</italic>
###xml 1239 1255 1239 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Faecalibacterium</italic>
###xml 1261 1276 1261 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parabacteroides</italic>
###xml 1307 1314 1307 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t003">Table 3</xref>
###xml 1446 1464 1446 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acidaminococcaceae</italic>
###xml 1466 1484 1466 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Porphyromonadaceae</italic>
###xml 1486 1497 1486 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Megasphaera</italic>
###xml 1499 1508 1499 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dialister</italic>
###xml 1510 1526 1510 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Faecalibacterium</italic>
###xml 1532 1547 1532 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parabacteroides</italic>
###xml 1549 1556 1549 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t003">Table 3</xref>
###xml 827 835 <span type="species:ncbi:9606">patients</span>
In all three libraries, bacteria belonging to the Bacteroidetes phylum were the most abundant, containing more than the half of the sequences in each library (from 50.72% to 56.64%) but a relatively smaller proportion of OTUs (from 35.19% to 40.91%), whereas the Firmicutes phylum had the larger proportion of phylotypes (from 55.30% to 60.49%) with the less copious sequence numbers (from 41.43% to 45.95%) (Table 2). At the phylum level, the relative proportions of Bacteroidetes and Firmicutes were not significantly different among the three libraries, however, pairwise comparisons of each 16S rDNA library to every other library by using the online library compare tool at RDP-II (Naive Bayesian rRNA Classifier) revealed significant differences within the lower taxa levels (Table 3). In particular, in asymptomatic FMF patients in remission, the proportion of Enterobacteriaceae, Acidaminococcaceae, Ruminococcus and Megasphaera was significantly increased in comparison with control subjects, while Roseburia was significantly reduced (Table 3). In the active disease, the proportion of Prevotellaceae, Dialister and Prevotella was significantly lower than in healthy controls while the Porphyromonadaceae, Phascolarctobacterium, Faecalibacterium, and Parabacteroides were significantly increased (Table 3). Interestingly, there were also differences due to the disease state (remission or attack) and the affected bacterial groups were Acidaminococcaceae, Porphyromonadaceae, Megasphaera, Dialister, Faecalibacterium, and Parabacteroides (Table 3).
###end p 28
###begin title 29
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Comparison of 16S rRNA gene libraries derived from healthy controls and FMF patients in remission and attack.
###end title 29
###begin p 30
p<0.01, comparison of remission vs. control libraries.
###end p 30
###begin p 31
p<0.01, comparison of attack vs. control libraries.
###end p 31
###begin p 32
p<0.01, comparison of remission vs. attack libraries.
###end p 32
###begin title 33
Community analysis of 16S rDNA libraries
###end title 33
###begin p 34
###xml 128 135 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t004">Table 4</xref>
###xml 762 769 762 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t004">Table 4</xref>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 510 518 <span type="species:ncbi:9606">patients</span>
###xml 836 844 <span type="species:ncbi:9606">patients</span>
###xml 917 925 <span type="species:ncbi:9606">patients</span>
The estimates of diversity, richness, evenness and library coverage for the three 16S rDNA clone libraries studied are shown in Table 4. At the phylotype level, the most diverse gut bacterial community was observed in FMF patients in remission. The slightly lower indices were found for the healthy microbiota, while the bacterial diversity during disease attacks was consistently lower. The similar trend was observed for another community parameter, species richness, which was the highest in the gut of FMF patients in remission and in healthy volunteers but much lower during disease attacks. On the contrary, evenness index, which describes how evenly the individual sequences are represented in phylotypes, was the highest in the disease attack community (Table 4). Good's coverage was 89.35-90.73% for the sequence sets from FMF patients in remission and healthy controls but only 77.2% for sequences from FMF patients in attack reflecting the lower number of subjects and sequences collected.
###end p 34
###begin title 35
Indices of diversity, richness and evenness and library coverage for 16S rRNA gene libraries.
###end title 35
###begin p 36
Calculations were made based on OTU definition at 99% sequence identity.
###end p 36
###begin p 37
The values in parentheses are the 95% confidence intervals, which assess the precision of the richness estimates.
###end p 37
###begin p 38
###xml 219 225 219 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g001">Fig. 1</xref>
###xml 409 415 409 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g001">Fig. 1</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Rarefaction analysis of clone libraries essentially confirmed these findings and suggested that FMF patients in remission possess the most diverse gut bacterial community, which is even higher than in healthy subjects (Fig. 1). Because of limited number of sequences in the clone library from the acute disease, we extrapolated the curve using an empiric regression function (for details, see the footnote to Fig. 1). The extrapolated curve confirmed the initial findings suggesting diminished diversity of gut bacteria in FMF attack in comparison with disease remission and control.
###end p 38
###begin title 39
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Rarefaction curves obtained for clone libraries from healthy controls and FMF patients.
###end title 39
###begin p 40
###xml 365 366 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 421 422 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 468 469 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 590 598 <span type="species:ncbi:9606">patients</span>
The rarefaction curves were generated by plotting the number of phylotypes (defined at 99% level) against the number of clones sequenced. The shape of the curves of observed phylotype richness indicates a trend of diminishing chance of finding new phylotypes as the sampling continues. Data for library in attack were extrapolated by empiric regression function axx2bxexp(-cxx). Coefficient of regression determination (R2) was 99.9%. Regression statistics: adjusted R2 - 0.9991; standard error - 0.1720; a = 1.8690; b = 0.7104; c = 8.0466E-04. Healthy controls are shown in dark blue; FMF patients in remission - in red and attack - in green, the extrapolated curve is shown in light blue.
###end p 40
###begin p 41
###xml 81 87 81 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g002">Fig. 2</xref>
###xml 337 344 337 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g002">Fig. 2A</xref>
###xml 774 781 774 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g002">Fig. 2B</xref>
Collector's curves of the observed and estimated phylotype richness are shown in Fig. 2. In healthy subjects, both estimates, Chao1 and abundance-based coverage estimator (ACE), were highly similar and, up to the point of collection of ca. 320 clones, were in a steady and congruent increase together with the observed phylotype number (Fig. 2A). In this sampling area, almost any new clone sequence added represented a novel phylotype. Adding new sequences after this point, however, led to the gap expansion between the estimated and observed phylotype numbers suggesting repeated sampling of the phylotypes already present in the sample. In FMF remission, the gap between the observed and estimated phylotype richness was constant after the sampling point of 290 clones (Fig. 2B). Confirmatory to the previous analyses, the phylotype number estimates at the sampling point with 500 clones gave the higher numbers of phylotypes in FMF remission than in the norm (220 vs. 160). The difference between the estimates and observed phylotype richness is highest in acute FMF possibly reflecting the insufficient coverage in this group (77.2%).
###end p 41
###begin title 42
Collector's curves of the observed and estimated phylotype richness of 16S libraries.
###end title 42
###begin p 43
Collector's curves of the observed (shown in dark blue) and estimated (Chao1 (light blue) and ACE (red)) phylotype richness calculated for healthy subjects (A), FMF remission (B), and FMF attack (C) with the phylogenetic depth defined at 99% level.
###end p 43
###begin title 44
FISH analysis
###end title 44
###begin p 45
###xml 233 254 233 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
Twelve Cy3-labelled oligonucleotide probes that target the total and specific predominant groups of human gut bacteria were used in this study to enumerate bacteria in the feces of FMF patients and healthy controls (for details, see Materials and Methods). Hybridization signals were detected for all bacterial groups, indicating their presence as dominant microbiota in all fecal samples analyzed.
###end p 45
###begin p 46
###xml 329 336 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t005">Table 5</xref>
###xml 679 681 679 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 695 697 695 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 715 722 715 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t005">Table 5</xref>
###xml 852 854 852 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 633 641 <span type="species:ncbi:9606">patients</span>
FISH analysis revealed that the composition of fecal bacteria in FMF patients in both inactive and active phases of the disease is different from that of the healthy controls. The results of enumeration of bacterial cells in each group and their relative proportions versus the universal bacterial probe Eub338 are summarized in Table 5. All fecal samples were processed exactly in the same way and the count of cells hybridized with Eub338 can be calculated to give the absolute numbers of bacteria per gram of feces. No significant difference in concentration of total fecal bacteria was found between the healthy controls and FMF patients in remission, the mean values 5.47x1010/g and 5.12x1010/g, respectively (Table 5). In the acute stage of the disease, however, the concentration of bacteria in fecal material was substantially lower, at 3.56x1010/g.
###end p 46
###begin title 47
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Mean numbers of predominant bacteria in fecal samples of FMF patients in both stages of the disease and healthy controls detected by FISH.
###end title 47
###begin p 48
Mean count+/-SD.
###end p 48
###begin p 49
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
Counts 108 cells per gram of fecal specimen.
###end p 49
###begin p 50
The percentage relative to the total number of cells determined by Eub338.
###end p 50
###begin p 51
p<0.05 as compared to healthy controls.
###end p 51
###begin p 52
p<0.01 as compared to healthy controls.
###end p 52
###begin p 53
###xml 112 123 112 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroides</italic>
###xml 185 187 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 278 280 278 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 318 320 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 353 360 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t005">Table 5</xref>
###xml 386 407 386 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Clostridium coccoides</italic>
###xml 502 504 502 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 564 566 564 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 663 683 663 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. rectale-Roseburia</italic>
###xml 734 746 734 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. coccoides</italic>
###xml 1007 1034 1007 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fecalibacterium prausnitzii</italic>
###xml 1243 1245 1243 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1283 1285 1283 1285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1326 1328 1326 1328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1644 1659 1644 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R. flavefaciens</italic>
###xml 1660 1669 1660 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R. bromii</italic>
###xml 1697 1699 1697 1699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1737 1739 1737 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1779 1781 1779 1781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1920 1922 1920 1922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 2012 2014 2012 2014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 2111 2113 2111 2113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 2124 2133 2124 2133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atopobium</italic>
###xml 2273 2275 2273 2275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 2315 2317 2315 2317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 2351 2353 2351 2353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 2389 2404 2389 2404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bifidobacterium</italic>
###xml 2406 2424 2406 2424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacteriaceae</italic>
###xml 2429 2455 2429 2455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lactobacillus-Enterococcus</italic>
###xml 2700 2707 2700 2707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t005">Table 5</xref>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 386 407 <span type="species:ncbi:1532">Clostridium coccoides</span>
###xml 663 673 <span type="species:ncbi:39491">E. rectale</span>
###xml 734 746 <span type="species:ncbi:1532">C. coccoides</span>
###xml 1524 1532 <span type="species:ncbi:9606">patients</span>
###xml 1644 1659 <span type="species:ncbi:1265">R. flavefaciens</span>
###xml 1660 1669 <span type="species:ncbi:40518">R. bromii</span>
###xml 2200 2208 <span type="species:ncbi:9606">patients</span>
Among the taxonomic groups tested, the highest proportion was detected with the Bac303 probe, which targets the Bacteroides group. It gave the concentration of these bacteria at 1.51x1010/g (27.3% of total bacteria) in healthy controls, with elevation in FMF patients to 1.86x1010/g (39.1%) in remission and to 1.35x1010/g (38.6%) in the attack period (Table 5). Cluster XIVa bacteria (Clostridium coccoides group) was the second most abundant group enumerated with the Erec482 probe comprising 1.09x1010/g (21.1%) in the healthy controls and approximately 1.01x1010/g in both, FMF remission and attack phases (18% and 28.9% of total bacteria, respectively). The E. rectale-Roseburia probe Rrec584, which is a nested probe within the C. coccoides group (enumerated with Erec482), detected 6.5%, 8.3% and 18.0% within the total bacteria probe, Eub338, and 41.5%, 43.8% and 59.8% within the Erec482 probe in healthy controls, FMF remission and FMF attacks, respectively. There were significant populations of Fecalibacterium prausnitzii related bacteria (Fprau645), the second important group of butyrate producers within clostridial cluster IV, in all studied groups, with the tendency to increase in acute FMF. These bacteria comprised 0.54x1010/g (11.3%) in healthy controls, 0.5x1010/g (10.4%) in FMF remissions, and 0.53x1010/g (13.8%) in acute stage of FMF. Another group within clostridial cluster IV, ruminococci, which was detected with the combination of probes Rfla729 and Rbro730, demonstrated lower levels in FMF patients, especially in the acute phase of the disease, compared to healthy controls. In particular, the members of the R. flavefaciens/R. bromii group accounted for 0.59x1010/g (9.9%) in healthy controls, 0.29x1010/g (5.3%) in FMF remissions, and 0.09x1010/g (2.6%) in acute FMF. Similarly, clostridial cluster IX representatives, detected with the probe Prop853, were estimated to be at 0.64x1010/g (11%) in healthy group, whereas in FMF remission these bacteria were reduced to 0.44x1010/g (7.1%), with even more significant reduction in the acute stage of FMF, accounting for 0.13x1010/g (3.5%). Atopobium group also tended to be less represented in gut microflora of FMF patients compared with healthy subjects, steadily decreasing from 0.42x1010/g (7.8%) in healthy controls to 0.29x1010/g (6.3%) in remission and 0.17x1010/g (4.5%) in attack. Members of the Bifidobacterium, Enterobacteriaceae and Lactobacillus-Enterococcus groups, which were detected by the probes Bif164, EnterobacD and Lab158, respectively, did not reveal significant differences between the studied groups because they were found in low numbers and demonstrated high inter-individual variability (Table 5).
###end p 53
###begin p 54
###xml 548 555 548 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t006">Table 6</xref>
###xml 910 920 910 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. rectale</italic>
###xml 921 930 921 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Roseburia</italic>
###xml 1475 1483 1475 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t005">Tables 5</xref>
###xml 1488 1489 1488 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t006">6</xref>
###xml 382 390 <span type="species:ncbi:9606">patients</span>
###xml 910 920 <span type="species:ncbi:39491">E. rectale</span>
###xml 1210 1217 <span type="species:ncbi:9606">patient</span>
We also attempted to evaluate the difference in gut microbiota composition in remission and attack periods of disease in the "pure" form, when the genetic, phenotypic and environmental variables are removed from the analysis. For this, we monitored the intra-individual shifts in total and main gut bacterial populations during the remission and attack phases of the disease in two patients and these observations confirmed and reinforced the tendencies found between the larger combined cohorts of FMF sufferers in the remission and acute stages (Table 6). First, the total numbers of bacteria in the gut enumerated with the Eub338 probe decreased about two-fold. Second, in a number of bacterial groups, the tendencies detected earlier became more profound and statistically significant. In particular, these changes included a dramatic increase in concentration of cluster XIVa bacteria and particularly of E. rectale-Roseburia cluster during the acute phase of the disease, with the reduction in concentration of cluster IX bacteria and ruminococci. The fall of proportion of populations of lactic acid bacteria enumerated with the Bif164 and Lab158 probes during the disease attack was significant in one patient, FMF 13-123, while in the other, FMF 87, the differences in this group were not significant. Thus, the monitoring of intra-individual bacterial shifts during the remission and attack phases validated and confirmed the findings involving the larger cohorts (Tables 5 and 6).
###end p 54
###begin title 55
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Distribution of main bacterial groups in two FMF patients in remission and attack.
###end title 55
###begin p 56
Mean count of the percentage relative to the total number of cells determined by Eub338 +/- SD.
###end p 56
###begin p 57
###xml 98 99 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
The values in parentheses are the absolute numbers of cells determined by Eub338 +/- SD (counts 108 cells per gram of fecal specimen).
###end p 57
###begin p 58
N/D, not detected.
###end p 58
###begin p 59
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t007">Table 7</xref>
###xml 261 272 261 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroides</italic>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 440 448 <span type="species:ncbi:9606">patients</span>
The part of FMF patients was undergoing colchicine therapy and we compared the composition of gut bacteria in respect to this treatment (Table 7). There was no difference in acute disease but in remission a certain tendency to normalization was observed in the Bacteroides group and in clostridial cluster IX bacteria. Nevertheless, these differences were not statistically significant and the data sets of colchicine-treated and untreated patients were combined together for the microbiota analyses.
###end p 59
###begin p 60
###xml 189 195 189 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g003">Fig. 3</xref>
###xml 215 226 215 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroides</italic>
###xml 469 476 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g003">Fig. 3A</xref>
###xml 495 515 495 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. rectale-Roseburia</italic>
###xml 604 611 604 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g003">Fig. 3B</xref>
###xml 647 656 647 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atopobium</italic>
###xml 745 752 745 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g003">Fig. 3C</xref>
###xml 826 833 826 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g003">Fig. 3D</xref>
###xml 889 903 889 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F. prausnitzii</italic>
###xml 963 981 963 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g003">Fig. 3B, 3D and 3E</xref>
###xml 495 505 <span type="species:ncbi:39491">E. rectale</span>
###xml 816 824 <span type="species:ncbi:9606">patients</span>
###xml 889 903 <span type="species:ncbi:853">F. prausnitzii</span>
Multiple comparative analyses of relative proportions of bacterial populations in the gut of the three cohorts were performed using the Kruskal-Wallis test and the results are presented in Fig. 3. The proportion of Bacteroides was significantly higher in both diseased cohorts in comparison with the healthy controls, while the proportion of cluster XIVa bacteria was only increased in the acute phase of the disease in comparison with the control group and remission (Fig. 3A). The fraction of E. rectale-Roseburia cluster among total bacteria was substantially increased, especially in active disease (Fig. 3B), while bacteria of cluster IX and Atopobium decreased in the attack phase of the disease in comparison with controls and remission (Fig. 3C). The proportion of ruminococci was significantly lower in FMF patients (Fig. 3D), while no significant differences were detected among F. prausnitzii, bifidobacteria, lactic acid bacteria, and enterobacteria (Fig. 3B, 3D and 3E).
###end p 60
###begin title 61
Comparison of the main bacterial groups identified by FISH between healthy and diseased groups.
###end title 61
###begin p 62
###xml 139 147 <span type="species:ncbi:9606">patients</span>
Comparative analysis of relative proportions of bacterial groups detected by different oligonucleotide probes in fecal samples between FMF patients in remission and attack periods and healthy control group (by Kruskal-Wallis test for multiple comparisons). On box-and-whisker plots the points within boxes indicate the mean values of bacterial proportions, the boxes represent standard errors (SE) and the vertical bars represent standard deviations (SD).
###end p 62
###begin title 63
Distribution of main bacterial groups in respect to colchicine treatment.
###end title 63
###begin p 64
Mean count+/-SD.
###end p 64
###begin p 65
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
Counts 108 cells per gram of fecal specimen.
###end p 65
###begin p 66
The percentage relative to the total number of cells determined by Eub338.
###end p 66
###begin p 67
###xml 306 312 306 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003064-g004">Fig. 4</xref>
###xml 486 493 486 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t008">Table 8</xref>
###xml 1194 1201 <span type="species:ncbi:9606">patient</span>
Discriminant function analysis (DA) is a powerful tool to extract specific patterns in multiple datasets and we used this approach to analyze the specific gut microbiota distribution patterns in our three cohorts. The summary of discriminant function analysis with 20 subjects and 10 variables is shown in Fig. 4. It revealed three clusters in bacterial distribution that are highly specific, well separated and distinct for healthy controls, FMF remission, and FMF attack. As shown in Table 8, the total percentage of correct classification was 95%, thus 95% of total subjects were classified into the correct groups (100% in healthy controls, 83.3% in remission and 100% in attack). The validity of the variables in differentiating the groups was supported by the Wilks's lambda coefficient, which may vary from 0 to 1 (the smaller the lambda, the more the variable differentiates the groups), and in this case it had a value of 0.045. The F-test of Wilks's lambda, which is used to test if the discriminant model as a whole is significant, produced (20,16) = 2.95; p<0.016. There was only one case of misclassification from a total of 20 when the remission stage was assessed as acute. This patient refused the colchicine therapy and was suffering from very frequent FMF attacks and there is a possibility that at the time of sampling the microbiota was not restructured back to the composition specific for the remission stage. Thus the model displayed good predictive accuracy and suggested the specific patterns of gut microbiota distribution in the healthy and diseased states.
###end p 67
###begin title 68
Discriminant function analysis of FISH data.
###end title 68
###begin p 69
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 178 180 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 245 253 <span type="species:ncbi:301928">ellipses</span>
Number of variables in model: 10; grouping - 3 groups. Wilks's lambda coefficient - 0.045; F-test - (20,16) = 2.95, p<0.016. Root 1, 2 - discriminant functions 1 and 2 (1st and 2nd canonical roots). Regions of group distribution are outlined by ellipses; healthy is shown in blue triangles, remission - in red circles, and attack - in green squares.
###end p 69
###begin title 70
Classification table of correct estimates based on FISH variables.
###end title 70
###begin p 71
Statistical parameters of the discriminant model: Wilks's lambda coefficient - 0.045. Significance of the model: F (20,16) = 2.95; p<0.016.
###end p 71
###begin p 72
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apriori</italic>
apriori probability of correct classification.
###end p 72
###begin title 73
Discussion
###end title 73
###begin p 74
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Zoetendal1">[43]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Stewart1">[44]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-VanLimbergen1">[42]</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Manichanh1">[35]</xref>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Frank1">[36]</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Seksik1">[45]</xref>
###xml 1230 1234 1230 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Toivanen1">[46]</xref>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 698 706 <span type="species:ncbi:9606">patients</span>
###xml 949 954 <span type="species:ncbi:9606">human</span>
###xml 1097 1102 <span type="species:ncbi:10090">mouse</span>
This is the first work reporting the specific changes in the human gut microbiota due to the mutations in a single gene of the host. Suggestions that the composition of gut microbiota is host genotype-dependant have been proposed earlier [43], [44], however, these works were based on twin studies and the host genotype was not assessed. Gut inflammatory diseases such as IBD have been long known as having a substantial genetic predisposition component and a recent review of genome-wide scans reported on the seven confirmed and replicated cases of genetic susceptibility loci, with many more, however, that need independent confirmation and verification [42]. Although the gut microbiota of IBD patients was subjected to several diversity analyses [35], [36], [45], the host genetics was not assessed, most probably because of complicated genetics of IBD. Thus, uncovering the genetic mechanisms that are involved in regulation of composition of human gut microbiota remains a challenging task. Evidence obtained in a study of bacterium-derived cellular fatty acids in the stool samples of six mouse strains congenic for the major histocompatibility complex (MHC) suggested the importance of host immune system in this process [46]. The obvious advantage of our model is that the genetics of FMF is well defined and confined to a single gene thus facilitating the host genotype analysis. Thus, for the first time, we had the opportunity for direct comparison of the host and gut community genotypes.
###end p 74
###begin p 75
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Stoffman1">[47]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Yilmaz1">[50]</xref>
###xml 784 788 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Kogan1">[49]</xref>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 1248 1256 <span type="species:ncbi:9606">patients</span>
Initially, we genotyped the FMF patients and healthy controls for the presence of disease-specific mutations in exons 2 and 10 of the MEFV gene. In all clinically confirmed cases we were able to detect the presence of known mutations, all of them in exon 10, which encodes the SPRY/B30.2 domain. Among our very limited cohort of seven healthy controls of Armenian origin, one heterozygote was detected, suggesting that the mutation carrier rate in this population is at least 14%, which is within the range of carrier rates found in populations of other ethnic origin [47]-[50]. The high carrier frequency in affected populations suggests the selective advantage conferred by the heterozygous state but no perceptible biological advantage of the carrier state is presently identified [49]. Positive selection to maintain the high frequency of the heterozygotes should also overcome the negative selection imposed by the increased morbidity and mortality rates among the homozygotes and compounded heterozygotes. Clinical manifestations during the disease attack are consistent with a strong inflammatory response, with fever, massive influx of polymorphonuclear leukocytes into the affected tissues, neutrophilia, and acute-phase response. In some patients this leads to systemic amyloidosis resulting in renal failure and death.
###end p 75
###begin p 76
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Booth1">[51]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Chae1">[52]</xref>
###xml 1572 1576 1568 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Tunca1">[53]</xref>
###xml 1578 1582 1574 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Aypar1">[54]</xref>
###xml 1620 1624 1616 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Poland1">[55]</xref>
###xml 1858 1862 1854 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Kogan1">[49]</xref>
###xml 1103 1111 <span type="species:ncbi:9606">patients</span>
###xml 1680 1688 <span type="species:ncbi:9606">patients</span>
The penetrance of mutations that are all missense mutations, varied widely. Apart from the combined heterozygotes, which support the recessive nature of mutations, there were also simple heterozygotes but with different phenotypes. The simple heterozygosity in clinically confirmed disease was exclusively exemplified by a M694V mutation and, similarly to another study [51], suggested the autosomal dominant inheritance probably due to the importance of this residue in the interaction of pyrin with caspase-1 [52]. On the other end of the mutation spectrum is the simple M680I heterozygosity found in one of the healthy volunteers, C6b, which did not result in any clinical or subclinical (cytokine profile) FMF manifestation. Thus, depending on the locus involved, the outcome could be either an asymptomatic carrier state or a full-blown disease. In the case of M694V mutation, a 50% complementation by the normal allele may be not sufficient to provide the protection against clinical manifestations of the disease. This is the most abundant mutation in our FMF cohort and is present in 70% of the patients. Taking into the consideration the high penetrance and associated fitness cost of carrying this allele even in the heterozygous form it seems counterintuitive to suggest that it may confer any selective advantage in the heterozygous carrier state under the present day living conditions. Phenotypically, the asymptomatic heterozygous carriers of FMF mutations are characterized by the elevated levels of markers of inflammation such as CRP, SAA, and INF-gamma [53], [54] and by specific glycosylation of AGP [55]. Whether this subclinical inflammation in asymptomatic patients may be protective against specific pathogens, probably endemic for the Mediterranean basin, remains to be seen since the previous studies failed to identify such agents [49].
###end p 76
###begin p 77
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Manukyan1">[56]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Bonnet1">[57]</xref>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Tajima1">[58]</xref>
###xml 1178 1192 1178 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bifidobacteria</italic>
###xml 1514 1522 <span type="species:ncbi:9606">patients</span>
###xml 1543 1551 <span type="species:ncbi:9606">patients</span>
In a parallel study, we measured the levels of systemic markers of inflammation in acute phase and remission of FMF [56]. The study confirmed earlier observations that even in remission, where the clinical signs of disease are absent, the level of certain markers of inflammation remains elevated suggesting chronic subclinical inflammation in FMF. How this inflammation may affect the gut microbiota? To answer this question, we used two independent techniques to assess gut molecular bacterial diversity in health and disease, the sequence analysis of 16S rRNA gene libraries and FISH. Both these techniques have their own advantages and disadvantages but in combination they are complementary and allow obtaining a more balanced overview of gut microbiota. In particular, 16S libraries may suffer from PCR biases introduced by elevated number of cycles [57] or poor amplification of certain templates [58] while FISH analysis is less sensitive since it targets higher taxonomic entities and no community analysis involving individuals and species/phylotypes, unless they very are numerous, is possible. On the other hand, FISH technique consistently detects higher levels of Bifidobacteria than clone library sequencing, it is less expensive and can be easily automated in conjunction with flow cytometry or computer-aided automatic count under the microscope for analysis of large cohorts. In order to minimize inter-individual variations, 16S rRNA gene libraries were constructed from fecal samples of 12 FMF patients in remission, three patients in the acute stage of FMF, six healthy Armenians, and one healthy subject of non-Armenian origin. The number of amplification cycles was maintained low (10 cycles) to prevent a potential PCR bias.
###end p 77
###begin p 78
###xml 177 180 177 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Ley2">[8]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Frank1">[36]</xref>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Eckburg1">[59]</xref>
###xml 299 312 299 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroidetes</italic>
###xml 317 327 317 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firmicutes</italic>
###xml 339 352 339 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroidetes</italic>
###xml 434 444 434 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firmicutes</italic>
###xml 539 552 539 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroidetes</italic>
###xml 780 790 780 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firmicutes</italic>
###xml 1058 1067 1058 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atopobium</italic>
###xml 1077 1092 1077 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bifidobacterium</italic>
###xml 1319 1333 1319 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bifidobacteria</italic>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 969 974 <span type="species:ncbi:9606">human</span>
Both analyses of gut microbiota produced the similar results in terms of general distribution of major phyla representatives in the human gut. Similarly to the previous studies [8], [36], [59] the vast majority of bacterial sequences and cells hybridized to specific probes in the gut fell into the Bacteroidetes and Firmicutes phyla. The Bacteroidetes contained the largest number of sequences but fewer phylotypes while the diverse Firmicutes were dominant in terms of the numbers and the relative proportion of phylotypes detected. The Bacteroidetes was also the largest group detected by the Bac303 probe accounting for 27-39% of the total bacterial count, which is lower than the clone library estimates. On the contrary, the combination of various FISH probes targeting the Firmicutes produced a higher estimate of bacteria belonging to this phylum than the clone libraries. The most profound difference between the two techniques in detection of bacteria in the human gut, however, concerned the enumeration of high G+C Gram-positive bacteria such as Atopobium spp. and Bifidobacterium spp.: FISH technique consistently detected a sizable population of these genera in the gut while they were hardly represented in PCR-generated libraries. Taking into the consideration an important role played by, for example, Bifidobacteria in maintaining the gastrointestinal health, consistent underestimates of these bacteria in clone library analyses may obscure the effect of this group in various gut diseases such as IBD as well as in the healthy gut.
###end p 78
###begin p 79
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 444 462 444 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Porphyromonadaceae</italic>
###xml 464 485 464 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phascolarctobacterium</italic>
###xml 487 503 487 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Faecalibacterium</italic>
###xml 509 524 509 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parabacteroides</italic>
###xml 560 585 560 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prevotellaceae, Dialister</italic>
###xml 590 600 590 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prevotella</italic>
###xml 874 906 874 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acidaminococcaceae, Megasphaera,</italic>
###xml 911 921 911 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dialister.</italic>
###xml 1384 1395 1384 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroides</italic>
###xml 1475 1489 1475 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prevotellaceae</italic>
###xml 1494 1512 1494 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Porphyromonadaceae</italic>
###xml 1530 1540 1530 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prevotella</italic>
###xml 1545 1560 1545 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parabacteroides</italic>
###xml 1824 1831 1824 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t005">Table 5</xref>
###xml 1896 1903 1896 1903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t003">Table 3</xref>
###xml 2135 2150 2135 2150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bifidobacterium</italic>
###xml 2155 2164 2155 2164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atopobium</italic>
###xml 2240 2244 2240 2244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Eckburg1">[59]</xref>
Examination of gut bacterial diversity in healthy and diseased cohorts by the two methods arrived essentially at the same conclusion suggesting the specific shifts in composition of bacteria imposed by mutations in the MEFV gene of the host. The gut microbiota in active disease was characterized by diminished bacterial diversity and major population restructuring within the phyla. In particular, the proportion of phylotypes belonging to of Porphyromonadaceae, Phascolarctobacterium, Faecalibacterium, and Parabacteroides were significantly increased while Prevotellaceae, Dialister and Prevotella were significantly lower in acute disease in comparison with control. Both approaches detected the fall in proportion of clostridial cluster IX in FMF attack: FISH demonstrated it for the whole group, while the sequence libraries elaborated this general trend as involving Acidaminococcaceae, Megasphaera, and Dialister. Evenness values for microbiota in active disease were higher reflecting the lower number of dominant phylotypes, although this could be a consequence of the smaller number of sequences collected. Also, in a parallel FISH approach, the fall in absolute numbers of bacteria during the inflammation attacks was detected. In most cases, this analysis is less sensitive than sequencing because it targets the larger taxonomic entities such as, for example, the whole Bacteroides group and cannot detect the differences at the lower taxa levels, e.g., in the Prevotellaceae and Porphyromonadaceae families and the Prevotella and Parabacteroides genera while sequence analysis operating at the individual sequence level is capable to do. In some cases, however, the situation may be opposite: Rfla729/Rbro730 FISH probe, for example, detects a subset of ruminococci, which is significantly reduced in attack (Table 5), while at the genus level the differences are not significant (Table 3). Thus, FISH served as a complementary tool and allowed analyzing bacterial populations that are routinely underestimated in sequence analyses. In particular, FISH detected the fall in absolute numbers of high G+C bacteria such as Bifidobacterium and Atopobium, which are not represented well in our and others SSU rRNA clone libraries [59]. Thus, in disease attack, the drop of total bacterial count and restructuring of bacterial composition in the gut may be the consequence of acute inflammation, which is accompanied by fever and influx of polymorphonuclear neutrophils (PMNs) into the affected areas including peritoneum. Elevated body temperatures (up to 40degreesC) and the localized respiratory burst of PMNs producing reactive oxygen species could be responsible for gut microbiota selection.
###end p 79
###begin p 80
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Manukyan1">[56]</xref>
###xml 812 820 <span type="species:ncbi:9606">patients</span>
###xml 1457 1465 <span type="species:ncbi:9606">patients</span>
As mentioned earlier, despite the absence of any clinical signs of disease in remission, certain systemic markers of inflammation are still elevated suggesting subclinical chronic inflammation [56]. Interestingly, the diversity values in remission were higher than in the healthy gut suggesting that the low-level subclinical inflammation in FMF may favour a greater diversity of intestinal bacteria. DA analysis of FISH data also confirmed the specific composition of bacterial populations in remission, which is different from control and forms a separate cluster. An additional internal control subject of different ethnic background was included in our study and the classification of the subject was consistently in the healthy group. The specific shifts of bacterial composition were also confirmed in two patients that were investigated during the remission and attack periods to exclude the influence of other genetic or environmental factors and these analyses confirmed the specific bacterial composition shifts due to disease state such as the increase of butyrate producers and the fall of clostridial cluster IX bacteria during disease attacks. While these shifts in attack may be explained by factors such as acute inflammation, with fever and PMN infiltration, the factors that govern the specific bacterial shifts in remission, which is free of disease symptoms, are harder to suggest. Nevertheless, our DA model consistently classified the patients in remission as a separate group, which suggests the specific patterns of gut microbiota in this cohort.
###end p 80
###begin p 81
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Ting1">[38]</xref>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Centola1">[60]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Diaz1">[62]</xref>
###xml 989 993 989 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Chae2">[63]</xref>
###xml 1321 1325 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Chae1">[52]</xref>
###xml 1327 1331 1324 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Papin1">[64]</xref>
###xml 1559 1563 1550 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Chae1">[52]</xref>
###xml 1768 1772 1759 1763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 1844 1848 1835 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Notarnicola1">[65]</xref>
###xml 2318 2322 2309 2313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 2590 2614 2581 2605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus, Listeria</italic>
###xml 2695 2699 2686 2690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Martinon1">[66]</xref>
###xml 2700 2704 2691 2695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Petrilli1">[71]</xref>
###xml 3205 3209 3193 3197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Davtyan1">[72]</xref>
###xml 3285 3289 3273 3277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Mariathasan2">[73]</xref>
###xml 1801 1809 <span type="species:ncbi:9606">patients</span>
###xml 2590 2604 <span type="species:ncbi:1280">Staphylococcus</span>
###xml 3085 3093 <span type="species:ncbi:9606">patients</span>
Thus the question is: what are the molecular mechanisms responsible for these microbiota shifts imposed by the mutated version of pyrin? In a broad sense, the functional role of this protein is the regulation of innate immunity [38]. The protein is expressed in granulocytes, activated monocytes, and serosal and synovial fibroblasts [60]-[62]. Recently it becomes evident that the regulatory functions of pyrin are carried out through the interaction of two domains of the protein, PYRIN and B30.2/rfp/SPRY, with the proinflammatory caspase-1 activating complex, called the inflammasome. The N-terminal PYRIN domain of the protein binds and competes for ASC (apoptosis-associated speck-like protein containing a caspase-recruitment domain), an inflammasome component, thereby decreasing its availability for the cryopyrin/NALP3/CIAS1 inflammasome. This results in reduction of caspase-1 activation and pro-interleukin-1beta processing and secretion thus halting the inflammatory response [63]. The mutational hotspot in FMF, however, is located in the C-terminal B30.2/rfp/SPRY domain, which modulates the inflammatory response through the interaction with several components of the inflammasome. In addition to interaction with cryopyrin/NALP3/CIAS1, it interacts directly with caspase-1 and its substrate pro-IL-1beta [52], [64]. The net effect of these interactions is the suppression of IL-1beta activation and block of inflammation. It was suggested that the heightened IL-1beta responsiveness could be a factor selecting for mutations in the MEFV gene [52]. Taking into consideration the overall role of pyrin as a modulator/suppressor of the inflammatory response, another factor contributing to the autoinflammatory nature of the disease could be the reduced MEFV messenger RNA expression in patients with familial Mediterranean fever [65]. First, it may contribute to the lower titre of pyrin and its PYRIN domain molecules in the cell thus making more ASC molecules available to initiate caspase-1 activation. Second, the reduced concentration of pyrin and therefore of its B30.2/rfp/SPRY domain, which, in addition, is mutated to the loss of caspase-1 suppressor function in most of FMF cases, may provoke easier triggering the inflammation cascade through caspase-1 activation. Thus, both consequences of MEFV mutations may lead to the heightened responsiveness of cryopyrin/NALP3/CIAS1, which can be oligomerized and activated in response to a very diverse range of ligands such as bacterial muramyl dipeptide, ATP, toxins, bacterial and viral RNA, small antiviral compounds, Staphylococcus, Listeria, and uric acid crystals as well as by low intracellualr potassium concentration [66]-[71]. While these exo- and endogenous stimuli are normally not perceived as danger signals or are efficiently suppressed, the facilitated oligomerization of the cryopyrin/NALP3/CIAS1, which is not adequately suppressed by the mutated pyrin in FMF, may be the underlying cause in this disease, resulting in excessive pro-caspase-1 and pro-IL1beta processing. Indeed, monocytes from FMF patients in remission fail to induce LPS homologous tolerance and exhibit heightened sensitivity to bacterial endotoxin [72], one of the important activators of the cryopyrin/NALP3/CIAS1 inflammasome [73].
###end p 81
###begin p 82
###xml 1083 1087 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Garrett1">[37]</xref>
In conclusion, we established in this work that mutations in a single host gene lead to specific restructuring of commensal gut microbiota. Although the exact molecular mechanisms behind this process are not fully understood, at our current genetic stage of analysis the work points to the host genotype as a key factor in symbiotic host-microbe interaction. Further developments in this area may focus on details of this interaction at the biochemical and physiological levels. Other models of gut inflammation such as IBD may help to establish the role of other host genes affecting the composition of commensal gut microbiota. Comparative community analyses from genetically different hosts are particularly interesting in identifying gut microbiota alterations specific for a particular disease genotype. At the same time, it cannot be excluded that the changes in the community structure may share some common features reflecting the similarities in disease phenotypes such as inflammation. And finally, how the gut microbiota is transformed in disease to become a "pathobiota" [37] remains an interesting question to answer.
###end p 82
###begin title 83
Materials and Methods
###end title 83
###begin title 84
Subjects and sampling
###end title 84
###begin p 85
###xml 203 210 203 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t001">Table 1</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Livneh1">[74]</xref>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 581 589 <span type="species:ncbi:9606">patients</span>
###xml 718 726 <span type="species:ncbi:9606">patients</span>
###xml 831 838 <span type="species:ncbi:9606">patient</span>
A total of 19 Armenian FMF patients with clinically confirmed disease, seven healthy individuals of the same ethnic background, and one healthy subject of non-Armenian origin participated in this study (Table 1). All FMF cases were diagnosed based on Tel-Hashomer criteria [74]. Blood and fecal samples were collected from FMF patients (15 males, four females; aged from 15 to 64 years, mean age-27 years) and control subjects (one male, seven females; aged from 32 to 67 years, mean age-43.8 years) for genotyping and gut bacterial diversity analyses (see below). None of the FMF patients and healthy individuals had used antibiotics within the three months prior to sampling. In the beginning of this study, ten FMF patients were not receiving any drugs and nine were undergoing regular colchicine therapy. During the study, one patient from the colchicine-free group was prescribed this therapy. All subjects were informed about the aim of this study and gave their consent to participate in it. The study was approved by the local ethical committee at IMB.
###end p 85
###begin title 86
Genetic diagnostics
###end title 86
###begin p 87
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 566 592 566 592 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATTCTCTCTCCTCTGCCCTG-3&#8242;</named-content>
###xml 603 629 603 629 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCATTCTTTCTCTGCAGCCG-3&#8242;</named-content>
###xml 707 734 707 734 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAGAAGAACTACCCTGTCCC-3&#8242;</named-content>
###xml 747 773 747 773 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCTCCTCTGAAATCCATGG-3&#8242;</named-content>
###xml 804 808 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Brydges1">[39]</xref>
###xml 930 931 926 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1923 1927 1885 1889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEFV</italic>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Venous blood samples were obtained from the clinically confirmed 19 FMF patients and eight healthy controls to reveal the MEFV mutation carrier status. Genetic analysis was based on screening of two mutational hot spots in the MEFV gene (exons 2 and 10). For this, genomic DNA was isolated from the anticoagulated venous blood samples using the Wizard Genomics DNA Purification kit (Promega, UK), according to the manufacturer's instructions. Exon 2 of the MEFV gene was PCR amplified from genomic DNA using a newly designed forward and reverse primer set: Exon2F - 5'-ATTCTCTCTCCTCTGCCCTG-3', Exon2R - 5'-CCATTCTTTCTCTGCAGCCG-3', yielding a 839 bp amplicon. Exon 10 was amplified using the primers Exon10F 5'-CCAGAAGAACTACCCTGTCCC-3' and Exon10R 5'-TCCTCCTCTGAAATCCATGG-3', yielding a product of 887 bp [39]. For exon 10, amplification was performed in a final volume of 50 microl, in a mix containing 10 mM Tris-HCl, 1.5 mM MgCl2, 50 mM KCl, 200 microM of each dNTP, 10.0 pmol of each primer, approximately 20 ng of genomic DNA, and 1 U of Red Taq polymerase (Bioline, UK). The cycling conditions included the initial denaturation step for 5 min at 94degreesC, followed by 35 cycles consisting of denaturation at 94degreesC for 30 sec, annealing at 61degreesC for 60 sec, and extension at 72degreesC for 60 sec, with a final extension at 72degreesC for 10 min. For exon 2, PCR amplification was performed similarly, except that the PCR mix contained 1 M betaine (Sigma-Aldrich, UK). Amplicons of the expected size were excised from 1.5% agarose gel and purified using a Wizard SV Gel and PCR Clean-up system (Promega, UK), according to the manufacturer's instructions. Purified PCR products were sequenced on both directions, using the same primer set as for generation of templates and the sequences were read on an automated 8-channel capillary sequencer (Beckman, USA) The wild-type sequences of exons 2 and 10 of the MEFV gene were retrieved from GenBank (accession number AF111163).
###end p 87
###begin title 88
Generation of 16S rDNA clone libraries
###end title 88
###begin p 89
###xml 394 401 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t001">Table 1</xref>
###xml 841 867 841 867 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGAGTTTGATCMTGGCTCAG-3&#8242;</named-content>
###xml 894 910 894 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 937 964 937 964 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACGGCTACCTTGTTACGACTT-3&#8242;</named-content>
###xml 996 1003 996 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Weisburg1">[75]</xref>
###xml 1085 1086 1085 1086 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1320 1324 1312 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Bonnet1">[57]</xref>
###xml 2085 2092 2043 2050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 2440 2443 2390 2393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lac</italic>
###xml 2723 2749 2659 2685 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATTAACCCTCACTAAAGGGA-3&#8242;</named-content>
###xml 2759 2785 2695 2721 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAATACGACTCACTATAGGG-3&#8242;</named-content>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
###xml 287 295 <span type="species:ncbi:9606">patients</span>
###xml 408 415 <span type="species:ncbi:9606">patient</span>
###xml 894 910 <span type="species:ncbi:562">Escherichia coli</span>
###xml 996 1003 <span type="species:ncbi:562">E. coli</span>
###xml 2085 2092 <span type="species:ncbi:562">E. coli</span>
In order to derive a detailed phylogenetic inventory of the gut microflora in FMF and in healthy controls, we constructed bacterial 16S rDNA gene libraries from fecal samples. For this, freshly voided feces were collected into sterile containers from 12 FMF patients in remission, three patients in the acute stage of FMF, six healthy Armenians, and one healthy subject of non-Armenian origin (Table 1). One patient, FMF 13-123, provided the samples both in remission and attack. Total DNA was extracted from fecal samples using QIAamp DNA Stool Mini Kit (Qiagen, UK), according to the manufacturer's instructions. DNA was additionally purified by phenol-chloroform-isoamyl alcohol (25:24:1) extraction, ethanol precipitated, and dissolved in TE buffer. Amplification of the 16S rRNA genes was carried out with the universal primer set-27F (5'-AGAGTTTGATCMTGGCTCAG-3'; positions 8 to 27 in the Escherichia coli 16S rRNA gene) and 1492R (5'-ACGGCTACCTTGTTACGACTT-3'; positions 1510 to 1492 in the E. coli 16S rRNA gene) [75]. The PCR reaction mixture contained 10 mM Tris-HCl, 2 mM MgCl2, 50 mM KCl, 200 microM of each dNTP, 10.0 pmol of each primer, 1U of Bio-X-Act Short DNA polymerase (Bioline, UK), and 100 ng of template DNA in a final volume of 50 microl. To reduce PCR bias caused by elevated number of PCR cycles [57], amplifications were performed using the following conditions: initial denaturation of template DNA at 94degreesC for 5 min, followed by 10 cycles of denaturation at 94degreesC for 30 sec, annealing at 57degreesC for 30 sec, and extension at 72degreesC for 2 min, with a final extension at 72degreesC for 10 min. PCR products were visualized on 1% agarose gel in TBE buffer stained with GelStar (Cambrex, UK). 16S PCR products were purified using Wizard SV Gel and PCR Clean-up system (Promega, UK), according to the manufacturer's instructions. This was followed by ethanol precipitation and the final pellets were suspended in 5 microl of TE buffer (pH 8.0). The purified PCR products were directly cloned into pCR-4 cloning vector and then transformed into E. coli TOP10 chemically competent cells using the TOPO TA Cloning Kit (Invitrogen, UK), according to the manufacturer's protocols. Colonies were blue/white screened on Luria-Bertani (LB) agar plates supplemented with ampicillin (50 microg/ml) and X-Gal (80 microg/ml). No IPTG was necessary in this system because the strain and plasmid do not carry the lac repressor. White recombinant colonies were randomly picked up into 200 microl of LB medium with ampicillin (50 microg/ml) in a 96-well format, sealed with a gas-permeable membrane, and incubated overnight at 37degreesC in a horizontal shaker. Two insert-surrounding primers, T3 (5'-ATTAACCCTCACTAAAGGGA-3') and T7 (5'-TAATACGACTCACTATAGGG-3') were used to amplify inserts using a 35-cycle colony PCR. Products were visualized after electrophoresis on 1% agarose gel in TAE buffer and ethidium bromide staining.
###end p 89
###begin title 90
Sequencing and phylogenetic analysis
###end title 90
###begin p 91
###xml 192 218 192 218 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCGTCAATTCCTTTGAGTTT-3&#8242;</named-content>
###xml 248 255 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Lane1">[76]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Thompson1">[77]</xref>
###xml 931 935 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Saitou1">[78]</xref>
###xml 1213 1217 1213 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Eckburg1">[59]</xref>
###xml 1423 1427 1423 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Schloss1">[79]</xref>
###xml 248 255 <span type="species:ncbi:562">E. coli</span>
Successfully amplified 16S rDNA inserts were purified and sequenced on the automated 8-channel capillary sequencers (Beckman, USA). The sequencing reactions were carried out with 926R primer (5'-CCGTCAATTCCTTTGAGTTT-3'; positions 926 to 907 in the E. coli 16S rRNA gene) [76]. Nucleotide sequences were aligned using the multiple sequence alignment program CLUSTALX v1.83 [77]. Each sequence was manually edited in conjunction with its chromatogram. Sequences were examined for the possible chimeras using CHIMERA_CHECK online analysis at RDP-II website (). Similarity search of the 16S rDNA sequences against database entries was performed using online Basic Local Alignment Search Tool (BLAST) program at the NCBI website (). Distance and similarity matrices were constructed with the DNADIST program v3.6 from PHYLIP () according to the Jukes-Cantor model. Phylogenetic analysis was performed using the neighbour-joining method [78]. Statistical significance of branching was verified by bootstrap analysis involving the construction and analysis of 1000 trees from bootstrapped data sets. Operational taxonomic units (OTUs), or phylotypes, were defined at 99% level as recommended for gut microbiota analyses [59]. To assign sequences quickly and accurately to OTUs, additionally, Jukes-Cantor corrected distance matrices were analyzed with DOTUR (Distance-Based OTU and Richness) by using the furthest-neighbor method [79].
###end p 91
###begin p 92
###xml 140 166 140 166 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGAGTTTGATCMTGGCTCAG-3&#8242;</named-content>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 223 247 223 247 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTATTACCGCGGCTGCTG-3&#8242;</named-content>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Lane1">[76]</xref>
###xml 314 343 314 343 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- ACGGCTACCTTGTTACGACTT -3&#8242;</named-content>
###xml 375 382 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 193 200 <span type="species:ncbi:562">E. coli</span>
###xml 277 284 <span type="species:ncbi:562">E. coli</span>
###xml 375 382 <span type="species:ncbi:562">E. coli</span>
About the half of OTUs (165 out of 346) were sequenced to completion. For this, a set of additional three universal bacterial primers, 27F (5'-AGAGTTTGATCMTGGCTCAG-3'; positions 8 to 27 in the E. coli 16S rRNA gene), 519R (5'-GTATTACCGCGGCTGCTG-3'; positions 536 to 519 in the E. coli 16S rRNA gene) [76] and RP2 (5'- ACGGCTACCTTGTTACGACTT -3'; positions 1510 to 1492 in the E. coli 16S rRNA gene) was used. These partial rRNA gene sequences (the average single sequence read length was approximately700 bp), including the sequence previously generated by the 926R primer, were assembled with ChromasPro v1.33 program to produce a consensus sequence for each of the 165 clones. Initially, all sequence data were assembled according to their overlapping sequence fragments into a contiguous consensus sequence using default program settings or, in some cases, adjusting the program settings, if necessary, followed by verification by eye. Afterwards, all chromatogram contigs obtained were manually edited removing ambiguous chromatogram areas, which resulted in the nearly full-length 16S bacterial rDNA sequences of about 1500 bp.
###end p 92
###begin p 93
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Saitou1">[78]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Felsenstein1">[80]</xref>
All full-length sequences were checked for possible chimeras using Chimera Check program, v2.7 (online analysis at Ribosomal Database Project II website, ). Chimeras and sequences of poor quality were omitted from further phylogenetic analyses. Phylogenetic analysis was performed in two stages. First, the almost full-length sequences from our libraries were combined with the closest relatives, cultivated and uncultivated, from databases, aligned, and subjected to phylogenetic analysis using the neighbor-joining method [78]. In the second stage, the partial sequences were aligned to the full-length sequence profile using the guide tree generated during the first stage. A total of 1328 validated 16S rDNA sequences participated in the final tree computing. Validation of the tree branching was done with bootstrap analysis [80] involving 1,000 reiterations with re-sampled data sets.
###end p 93
###begin title 94
Community structure analysis
###end title 94
###begin p 95
###xml 636 637 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 930 934 930 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Good1">[81]</xref>
Rarefaction and collector's curves of observed phylotypes, richness estimates and diversity indices were determined with DOTUR program using Jukes-Cantor corrected distance matrix. The bias-corrected Chao 1 richness estimator was calculated after 1000 randomizations of sampling without replacement. Collector's curves of observed and estimated (Chao 1 and the abundance-based coverage estimator, ACE) richness were constructed. Diversity was estimated by the Shannon and Simpson indices, the Simpson reciprocal index was calculated as 1/D, and another version of the Simpson diversity index-as 1-D. The evenness was calculated as E = eH/N, where H is the Shannon diversity index, N is the number of phylotypes. The Good's coverage percentage was calculated with the formula [1-(n/N)]x100, where n is the number of phylotypes in a sample represented by one clone (singletons) and N is the total number of sequences in that sample [81].
###end p 95
###begin title 96
Fluorescent in situ hybridization (FISH)
###end title 96
###begin p 97
###xml 191 198 191 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t009">Table 9</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Amann1">[82]</xref>
###xml 308 319 308 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroides</italic>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Manz1">[83]</xref>
###xml 364 385 364 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Clostridium coccoides</italic>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Franks1">[84]</xref>
###xml 430 459 430 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eubacterium rectale-Roseburia</italic>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Aminov1">[85]</xref>
###xml 537 565 537 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Faecalibacterium prausnitzii</italic>
###xml 621 625 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Suau1">[86]</xref>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Harmsen1">[87]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Walker1">[88]</xref>
###xml 800 815 800 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bifidobacterium</italic>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Langendijk1">[89]</xref>
###xml 836 845 836 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atopobium</italic>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Harmsen2">[90]</xref>
###xml 884 902 884 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacteriaceae</italic>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Ootsubo1">[91]</xref>
###xml 952 956 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Harmsen3">[92]</xref>
###xml 958 965 958 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t009">Table 9</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Franks1">[84]</xref>
###xml 1163 1183 1163 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. rectale-Roseburia</italic>
###xml 1246 1250 1246 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Aminov1">[85]</xref>
###xml 1364 1368 1364 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003064-Harmsen1">[87]</xref>
###xml 364 385 <span type="species:ncbi:1532">Clostridium coccoides</span>
###xml 430 449 <span type="species:ncbi:39491">Eubacterium rectale</span>
###xml 537 565 <span type="species:ncbi:853">Faecalibacterium prausnitzii</span>
###xml 1074 1079 <span type="species:ncbi:9606">human</span>
###xml 1163 1173 <span type="species:ncbi:39491">E. rectale</span>
FISH analysis was applied to quantify the predominant groups of bacteria in fecal samples using the universal bacterial and group-specific 16S rRNA-based Cy3-labelled oligonucleotide probes (Table 9). The probes hybridized with the next bacterial groups: Eub338 with the total bacteria [82]; Bac303 with the Bacteroides group [83]; Erec482 with the members of the Clostridium coccoides group (cluster XIVa) [84]; Rrec584 with the Eubacterium rectale-Roseburia cluster, which is a component of clostridial cluster XIVa [85]; Fprau645 for Faecalibacterium prausnitzii-related bacteria-a component of clostridial cluster IV [86]; the Rfla729 and the Rbro730 probes are specific for ruminococci in clostridial cluster IV [87]; Prop853 for the members of clostridial cluster IX [88]; Bif164 for the genus Bifidobacterium[89]; Ato291 for the Atopobium group [90]; EnterobactD for the genus Enterobacteriaceae[91]; and Lab158 for lactobacilli and enterococci [92] (Table 9). Together, the group-specific probes detected the vast majority of the total bacterial cells in the normal human gut [84]. The Rrec584 probe was excluded from this summation, since it detects the E. rectale-Roseburia cluster within the group already covered by the probe Erec482 [85]. The probe Rfla729 was used in conjunction with the probe Rbro730 as the target bacterial groups are overlapping [87].
###end p 97
###begin title 98
Oligonucleotide probes and hybridization conditions used in this study.
###end title 98
###begin p 99
T, Hybridization temperature (degreesC); F, Formamide concentration (%); L, Lysozyme treatment (min).
###end p 99
###begin p 100
###xml 169 176 169 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t001">Table 1</xref>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
Freshly voided feces from six FMF patients in remission, seven in the acute phase, six healthy Armenians and one healthy subject of non-Armenian descent were collected (Table 1). Two patients, FMF 13-123 and FMF 87, provided fecal samples at both disease stages. The samples in sterile plastic bags were kept at 4degreesC for no longer than 12 h prior processing. The specimens were kneaded mechanically for 5 min at 4degreesC to distribute the sample evenly. 0.5 g of each sample was suspended in 4.5 ml of filtered (0.2 microm pore-size filter) ice-cold phosphate-buffer-saline (PBS) and vortexed with a dozen of glass beads for at least 3 min to homogenize the sample and dislodge the bacteria from feed particles. The suspension was centrifuged at 700xg for 1 min to remove debris. One ml of supernatant was added to three ml of 4% paraformaldehyde (PFA) in PBS, fixed at 4degreesC for 16 hours, washed with ice-cold PBS, and stored in 50% (vol/vol) ethanol-PBS at -20degreesC until analysed.
###end p 100
###begin p 101
###xml 516 523 500 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t009">Table 9</xref>
###xml 941 948 915 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003064-t009">Table 9</xref>
Depending on the expected number of target cells, the samples were diluted 40- to 1600-fold, and 10 microl of a diluted bacterial suspension was applied to gelatin-coated slides, air-dried and fixed in 100% ethanol. 10 microl of 50 ng/microl solution of oligonucleotide probes in 100 microl of hybridization buffer was added to the slides and the samples were hybridized overnight (except for the Bac303 probe, which was incubated for 2 h) in a precision incubator at different temperatures, depending on the probe (Table 9). If more stringent conditions were required, formamide was added to the hybridization buffer. To improve bacterial cell permeability samples were incubated before hybridization in 10 microl of lysozyme (final concentration 1 mg/ml) in 100 mM Tris-HCl (pH 8.5) at 37degreesC. The full panel of FISH oligonucleotide probes with their target bacterial groups and hybridization conditions used in this study is shown in Table 9.
###end p 101
###begin p 102
After hybridization, the slides were soaked in a washing buffer for 20 min at 50degreesC, rinsed with Milli-Q water, and rapidly dried with compressed air. Slides then were covered with 50 microl of Vectashield (Vector Laboratories, Burlington, California) to prevent the fading of fluorescence and a coverslip. The enumeration was performed when the hybridization signals were clear and morphologically distinguishable. Bacterial cells were counted automatically using image analysis software Quantimet HR600 with a Leica DMRXA epifluorescence microscope (Wetzlar, Germany). Depending on the number of labelled cells, from 20 to 50 fields were counted to bring the coefficient of variance value below 10.
###end p 102
###begin title 103
Statistical analyses
###end title 103
###begin p 104
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
Statistical analyses were performed using the Statsoft Statistica package (). Comparisons were made among groups of subjects using the Mann-Whitney U test and Student's t-test. Multiple comparisons were carried out using Kruskal-Wallis test. In order to classify cases data were subjected to discriminant function analysis (DA). The P-values below 0.05 were considered statistically significant.
###end p 104
###begin p 105
Statistical comparison of 16S rDNA clone libraries was performed using online library compare tool at RDP-II website (). This tool uses the RDP Naive Bayesian classifier to provide rapid classification of library sequences into the bacterial taxonomy proposed by the Bergey's Trust. The P values <0.01 were considered as having significant differences.
###end p 105
###begin p 106
###xml 0 16 0 16 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Data deposition:</bold>
Data deposition: The sequences reported in this paper have been deposited in GenBank with accession numbers EU531867-EU532010 and EU532765-EU533948.
###end p 106
###begin p 107
We thank Sylvia Duncan, Alan Walker and Harry Flint for help with automated FISH.
###end p 107
###begin title 108
References
###end title 108
###begin article-title 109
###xml 70 75 <span type="species:ncbi:9606">human</span>
Ecological and evolutionary forces shaping microbial diversity in the human intestine.
###end article-title 109
###begin article-title 110
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Intestinal Microflora in Health and Disease.
###end article-title 110
###begin article-title 111
Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.
###end article-title 111
###begin article-title 112
Functional food science and gastrointestinal physiology and function.
###end article-title 112
###begin article-title 113
Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.
###end article-title 113
###begin article-title 114
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.
###end article-title 114
###begin article-title 115
The gut microbiota as an environmental factor that regulates fat storage.
###end article-title 115
###begin article-title 116
###xml 19 24 <span type="species:ncbi:9606">human</span>
Microbial ecology: human gut microbes associated with obesity.
###end article-title 116
###begin article-title 117
An obesity-associated gut microbiome with increased capacity for energy harvest.
###end article-title 117
###begin article-title 118
Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells.
###end article-title 118
###begin article-title 119
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.
###end article-title 119
###begin article-title 120
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 25 35 <span type="species:ncbi:7227">Drosophila</span>
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.
###end article-title 120
###begin article-title 121
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Nod1 confers responsiveness to bacterial lipopolysaccharides.
###end article-title 121
###begin article-title 122
Mammalian NLR proteins; discriminating foe from friend.
###end article-title 122
###begin article-title 123
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.
###end article-title 123
###begin article-title 124
###xml 87 93 <span type="species:ncbi:10090">murine</span>
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.
###end article-title 124
###begin article-title 125
Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C.
###end article-title 125
###begin article-title 126
Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.
###end article-title 126
###begin article-title 127
The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines.
###end article-title 127
###begin article-title 128
Butyrate, aspirin and colorectal cancer.
###end article-title 128
###begin article-title 129
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Butyrate and glucose metabolism by colonocytes in experimental colitis in mice.
###end article-title 129
###begin article-title 130
A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem.
###end article-title 130
###begin article-title 131
Glycan foraging in vivo by an intestine-adapted bacterial symbiont.
###end article-title 131
###begin article-title 132
Bacterial symbionts induce a FUT2-dependent fucosylated niche on colonic epithelium via ERK and JNK signaling.
###end article-title 132
###begin article-title 133
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human symbionts use a host-like pathway for surface fucosylation.
###end article-title 133
###begin article-title 134
Bacteria-host communication: the language of hormones.
###end article-title 134
###begin article-title 135
###xml 41 63 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Recognition of host immune activation by Pseudomonas aeruginosa.
###end article-title 135
###begin article-title 136
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
###end article-title 136
###begin article-title 137
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
###end article-title 137
###begin article-title 138
Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
###end article-title 138
###begin article-title 139
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
###end article-title 139
###begin article-title 140
Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
###end article-title 140
###begin article-title 141
Bacterial flagellin is a dominant antigen in Crohn disease.
###end article-title 141
###begin article-title 142
IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin.
###end article-title 142
###begin article-title 143
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach.
###end article-title 143
###begin article-title 144
###xml 77 82 <span type="species:ncbi:9606">human</span>
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.
###end article-title 144
###begin article-title 145
Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System.
###end article-title 145
###begin article-title 146
CATERPILLERs, pyrin and hereditary immunological disorders.
###end article-title 146
###begin article-title 147
The systemic autoinflammatory diseases: inborn errors of the innate immune system.
###end article-title 147
###begin article-title 148
Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever.
###end article-title 148
###begin article-title 149
A candidate gene for familial Mediterranean fever.
###end article-title 149
###begin article-title 150
The Genetics of Inflammatory Bowel Disease.
###end article-title 150
###begin article-title 151
###xml 57 62 <span type="species:ncbi:9606">human</span>
The host genotype affects the bacterial community in the human gastrointestinal tract.
###end article-title 151
###begin article-title 152
###xml 109 117 <span type="species:ncbi:9606">children</span>
Investigations into the influence of host genetics on the predominant eubacteria in the faecal microflora of children.
###end article-title 152
###begin article-title 153
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.
###end article-title 153
###begin article-title 154
Influence of major histocompatibility complex on bacterial composition of fecal flora.
###end article-title 154
###begin article-title 155
Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups.
###end article-title 155
###begin article-title 156
Familial Mediterranean fever: prevalence, penetrance and genetic drift.
###end article-title 156
###begin article-title 157
Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state.
###end article-title 157
###begin article-title 158
Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population.
###end article-title 158
###begin article-title 159
The genetic basis of autosomal dominant familial Mediterranean fever.
###end article-title 159
###begin article-title 160
The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.
###end article-title 160
###begin article-title 161
Acute phase response and evolution of familial Mediterranean fever.
###end article-title 161
###begin article-title 162
Th1 polarization in familial Mediterranean fever.
###end article-title 162
###begin article-title 163
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Specific glycosylation of alpha1-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV.
###end article-title 163
###begin article-title 164
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Cytokine profile of Armenian patients with Familial Mediterranean fever.
###end article-title 164
###begin article-title 165
Differences in rDNA libraries of faecal bacteria derived from 10- and 25-cycle PCRs.
###end article-title 165
###begin article-title 166
Diet-dependent shifts in the bacterial population of the rumen revealed with real-time PCR.
###end article-title 166
###begin article-title 167
###xml 17 22 <span type="species:ncbi:9606">human</span>
Diversity of the human intestinal microbial flora.
###end article-title 167
###begin article-title 168
The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.
###end article-title 168
###begin article-title 169
###xml 89 94 <span type="species:ncbi:9606">human</span>
Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures.
###end article-title 169
###begin article-title 170
###xml 92 97 <span type="species:ncbi:9606">human</span>
Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever.
###end article-title 170
###begin article-title 171
Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis.
###end article-title 171
###begin article-title 172
###xml 66 74 <span type="species:ncbi:9606">patients</span>
The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing.
###end article-title 172
###begin article-title 173
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever.
###end article-title 173
###begin article-title 174
Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.
###end article-title 174
###begin article-title 175
Cryopyrin activates the inflammasome in response to toxins and ATP.
###end article-title 175
###begin article-title 176
Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3.
###end article-title 176
###begin article-title 177
Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA.
###end article-title 177
###begin article-title 178
Gout-associated uric acid crystals activate the NALP3 inflammasome.
###end article-title 178
###begin article-title 179
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration.
###end article-title 179
###begin article-title 180
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Impaired endotoxin tolerance induction in patients with familial Mediterranean fever.
###end article-title 180
###begin article-title 181
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.
###end article-title 181
###begin article-title 182
Criteria for the diagnosis of familial Mediterranean fever.
###end article-title 182
###begin article-title 183
16S ribosomal DNA amplification for phylogenetic study.
###end article-title 183
###begin article-title 184
Rapid Determination of 16S Ribosomal RNA Sequences for Phylogenetic Analyses.
###end article-title 184
###begin article-title 185
The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
###end article-title 185
###begin article-title 186
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
###end article-title 186
###begin article-title 187
Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness.
###end article-title 187
###begin article-title 188
Confidence intervals on phylogenies: an approach using the bootstrap.
###end article-title 188
###begin article-title 189
The population frequencies of species and the estimation of population parameters.
###end article-title 189
###begin article-title 190
Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations.
###end article-title 190
###begin article-title 191
###xml 114 147 114 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cytophaga-Flavobacter-Bacteroides</italic>
Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum Cytophaga-Flavobacter-Bacteroides in the natural environment.
###end article-title 191
###begin article-title 192
###xml 39 44 <span type="species:ncbi:9606">human</span>
Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes.
###end article-title 192
###begin article-title 193
###xml 147 156 147 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Roseburia</italic>
###xml 165 184 165 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eubacterium rectale</italic>
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 165 184 <span type="species:ncbi:39491">Eubacterium rectale</span>
Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale.
###end article-title 193
###begin article-title 194
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fusobacterium prausnitzii</italic>
###xml 0 25 <span type="species:ncbi:853">Fusobacterium prausnitzii</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Fusobacterium prausnitzii and related species represent a dominant group within the human faecal flora.
###end article-title 194
###begin article-title 195
###xml 68 73 <span type="species:ncbi:9606">human</span>
Extensive set of 16S rRNA-based probes for detection of bacteria in human feces.
###end article-title 195
###begin article-title 196
###xml 136 141 <span type="species:ncbi:9606">human</span>
pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon.
###end article-title 196
###begin article-title 197
###xml 51 66 51 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bifidobacterium</italic>
Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples.
###end article-title 197
###begin article-title 198
###xml 45 59 45 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Coriobacterium</italic>
###xml 74 83 74 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atopobium</italic>
###xml 133 150 133 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Coriobacteriaceae</italic>
###xml 154 159 <span type="species:ncbi:9606">human</span>
Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups.
###end article-title 198
###begin article-title 199
###xml 36 54 36 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacteriaceae</italic>
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
Oligonucleotide probe for detecting Enterobacteriaceae by in situ hybridization.
###end article-title 199
###begin article-title 200
###xml 104 111 104 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in fecal samples by fluorescent in situ hybridization.
###end article-title 200
###begin p 201
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 201
###begin p 202
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by the ISTC (project A-1055). RIA is supported by the RERAD.
###end p 202

